We are live on ! Find out more
DWTX icon

Dogwood Therapeutics
DWTX

11 hedge funds and large institutions have $208K invested in Dogwood Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.03% less ownership

Funds ownership: 4.29% → 2.26% (-2%)

21% less funds holding

Funds holding: 14 → 11 (-3)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

71% less capital inflows, than outflows

Capital inflows: $81.6K | Capital outflows: $278K

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$81.5K
2
Raymond James Financial
Raymond James Financial
Florida
+$116
3
Bank of America
Bank of America
North Carolina
+$34

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$149K
2
FNY Investment Advisers
FNY Investment Advisers
New York
-$62K
3
HRT Financial
HRT Financial
New York
-$56K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$7.67K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$1.25K

DWTX Hedge Fund Activity: Q2 2025 in Review

11 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q2 2025, worth a combined $208K — down 49% from $410K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of DWTX and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, adding an estimated $81.5K. The largest seller was UBS Group, exiting entirely with an estimated $149K sold.

  • 11 institutional investors held Dogwood Therapeutics (DWTX) as of Q2 2025, down from 14 in Q1 2025.
  • Funds reported $208K of Dogwood Therapeutics stock for Q2 2025, down 49% quarter-over-quarter.
  • 1 fund opened new Dogwood Therapeutics positions in Q2 2025 and 4 closed out, a net change of -3 holders.
  • The largest Dogwood Therapeutics buyer in Q2 2025 was Morgan Stanley, an estimated $81.5K added.
  • The largest Dogwood Therapeutics seller in Q2 2025 was UBS Group, an estimated $149K sold.

Based on aggregated 13F filings for Q2 2025.